HealthTech Magazines July 9, 2020
Don’t get me wrong, Direct to Consumer (DTC) telemedicine (TM) is valuable in ways we haven’t even fully discovered. In the last few years, however, DTC platforms/companies have hit the market like Fitbits in 2016 and just like teens, every healthcare system has insisted they must have a DTC service if not before the competition, certainly to keep pace with “every” other organization. I have watched this affect healthcare, (a market traditionally thought to be somewhat protected from fads) in unbelievable ways. Organizations have spent incredible amounts of money without the usual six-month strategic analysis, followed by the six months of legal and risk review and most unbelievably without determining upfront the return on investment (ROI).
Having been in healthcare...